Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAllergy Thera. Share News (AGY)

Share Price Information for Allergy Thera. (AGY)

Share Price is delayed by 15 minutes
Get Live Data
7.50    -0.40 (-5.06%)
Bid:
7.00
Ask:
8.00
Spread: 1.00 (14.286%)
Market Cap: £474.94m
AGY Live PriceLast checked at - London Stock Exchange

Intraday Allergy Thera. Share Chart

Allergy Thera. News

IN BRIEF: Allergy Therapeutics study confirms peanut vaccine potential
3 Aug 2021

IN BRIEF: Allergy Therapeutics study confirms peanut vaccine potential

IN BRIEF: Allergy Therapeutics study confirms peanut vaccine potential

Allergy Therapeutics upbeat on ex-vivo study of peanut allergy vaccine
3 Aug 2021

Allergy Therapeutics upbeat on ex-vivo study of peanut allergy vaccine

(Sharecast News) - Pharmaceutical biotechnology company Allergy Therapeutics announced positive primary results from an ex-vivo biomarker study on Tue...

Allergy Therapeutics expects revenue rise in year despite challenges
14 Jul 2021

Allergy Therapeutics expects revenue rise in year despite challenges

Allergy Therapeutics expects revenue rise in year despite challenges

TRADING UPDATES: Vitec and Allergy Therapeutics lift full-year outlook
24 Jun 2021

TRADING UPDATES: Vitec and Allergy Therapeutics lift full-year outlook

TRADING UPDATES: Vitec and Allergy Therapeutics lift full-year outlook

Allergy Therapeutics FY profits seen 'well ahead' of expectations
24 Jun 2021

Allergy Therapeutics FY profits seen 'well ahead' of expectations

(Sharecast News) - Commercial biotechnology company Allergy Therapeutics said on Thursday that full-year operating profits were expected to be "well a...

TRADING UPDATES: Superdry optimistic; Virgin Wines toasts demand surge
6 May 2021

TRADING UPDATES: Superdry optimistic; Virgin Wines toasts demand surge

TRADING UPDATES: Superdry optimistic; Virgin Wines toasts demand surge

Allergy Therapeutics completes treatment in G309 field study
6 May 2021

Allergy Therapeutics completes treatment in G309 field study

(Sharecast News) - Commercial biotechnology company Allergy Therapeutics announced the completion of the treatment of all patients in its 'G309' explo...

TRADING UPDATES: Capita sells Irish unit; Daily Mail buys science mag
3 Mar 2021

TRADING UPDATES: Capita sells Irish unit; Daily Mail buys science mag

TRADING UPDATES: Capita sells Irish unit; Daily Mail buys science mag